000 01200 a2200337 4500
005 20250515183442.0
264 0 _c20091001
008 200910s 0 0 chi d
022 _a1009-3591
040 _aNLM
_beng
_cNLM
100 1 _aXia, Jin-Sheng
245 0 0 _a[The mTOR inhibitor enhances chemosensitivity of androgen-independent prostate cancer cell line].
_h[electronic resource]
260 _bZhonghua nan ke xue = National journal of andrology
_cJul 2009
300 _a617-20 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aCell Cycle
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPaclitaxel
_xpharmacology
650 0 4 _aProstatic Neoplasms
_xdrug therapy
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aSirolimus
_xanalogs & derivatives
700 1 _aChen, Xian-Guo
700 1 _aZhuang, Qian-Yuan
700 1 _aLiu, Ji-Hong
700 1 _aYe, Zhang-Qun
773 0 _tZhonghua nan ke xue = National journal of andrology
_gvol. 15
_gno. 7
_gp. 617-20
999 _c19096787
_d19096787